Designing a Lifestyle Medicine Clinical Pathway in Viet Nam: From Assessment and Risk Stratification to Referral, Follow-Up and Safety
LIFESTYLE MEDICINE IN VIET NAM


Designing a Lifestyle Medicine Clinical Pathway in Viet Nam: From Assessment and Risk Stratification to Referral, Follow-Up and Safety
Last reviewed: November 7, 2026
A Lifestyle Medicine program may have well-trained professionals, useful educational materials and patients who are genuinely interested in improving their health. Yet these strengths do not necessarily translate into reliable clinical care.
Consider a patient with type 2 diabetes who begins making substantial dietary changes while taking glucose-lowering medication. Their blood glucose levels may improve, but they may also develop hypoglycemia if treatment and monitoring are not reviewed appropriately. Another patient may be encouraged to exercise despite symptoms that require medical assessment. Someone experiencing significant psychological distress may receive general stress-management advice when more specific mental healthcare is needed.
In each situation, the problem is not necessarily that lifestyle intervention is inappropriate. It is that the intervention has been separated from the clinical decisions, professional responsibilities and safety processes that should accompany it.
This is why a clinical pathway matters.
When Lifestyle Medicine becomes part of healthcare, organizations need to know who should enter the pathway, what should be assessed, how risks are identified, when treatment should be modified, which situations require referral and who remains responsible for the patient after each step.
These questions are particularly relevant in Viet Nam, where the 2026 disease-prevention framework has strengthened national attention to noncommunicable diseases, risk-factor management and community-based care.
The challenge is not to build a separate healthcare system around Lifestyle Medicine. It is to integrate appropriate lifestyle interventions into existing clinical services in a way that is safe, evidence-based, professionally accountable and measurable.
A Clinical Pathway Is More Than a Consultation
A consultation is one encounter between a patient and a healthcare professional. A clinical pathway describes how care is organized across multiple encounters and, where necessary, multiple professionals or services.
It begins before an intervention is selected and continues after the patient leaves the consultation.
A useful pathway connects patient identification, assessment, clinical risk, intervention planning, referral, monitoring, treatment review and follow-up. It also establishes what should happen when a patient does not improve, experiences an unexpected problem or requires care beyond the capabilities of the current service.
The 2025 Lifestyle Medicine Core Competencies provide an international foundation for this approach. The framework includes 89 competencies covering lifestyle assessment, clinical decision-making, behavior change, multidisciplinary care, evidence appraisal, referral, follow-up, data use and quality improvement.
The competencies also recognize that some activities fall outside the professional scope of certain healthcare practitioners. Seven competencies are specifically identified as potentially outside the scope of non-provider healthcare professionals.
This distinction is important in Viet Nam because international professional competencies do not independently establish legal authorization to undertake clinical activities.
For healthcare organizations, the pathway must therefore connect three elements: what the scientific evidence supports, what the patient clinically needs and what the organization and its professionals are legally authorized and capable of providing.
The Vietnamese Legal Framework Defines the Boundaries of Clinical Practice
The Law on Disease Prevention No. 114/2025/QH15, effective July 1, 2026, provides an important foundation for strengthening disease prevention in Viet Nam. It addresses noncommunicable disease risk factors, including unhealthy behaviors and lifestyles, metabolic abnormalities and environmental influences. It also provides a framework for prevention, early identification, counseling and management of people with risk factors or established disease.
Decree No. 165/2026/NĐ-CP, effective on the same date, details and guides the implementation of selected provisions of the law.
Circular No. 15/2026/TT-BYT also came into effect on July 1, 2026, although its specific provisions should not be interpreted as establishing a dedicated Lifestyle Medicine clinical pathway.
These instruments strengthen the broader prevention environment. They do not create a separately licensed Lifestyle Medicine profession.
Clinical care remains governed by the Law on Medical Examination and Treatment, its applicable implementing regulations and the professional requirements associated with each regulated healthcare activity.
The current consolidated Law on Medical Examination and Treatment is contained in Consolidated Document No. 26/VBHN-VPQH, dated February 26, 2026. Decree No. 96/2023/NĐ-CP and Circular No. 32/2023/TT-BYT, as amended, are also important parts of the implementing framework.
One amendment requires particular attention because it contains two different effective dates.
Circular No. 25/2026/TT-BYT, issued on June 30, 2026, generally took effect on August 15, 2026. However, Article 6, Clause 2 expressly provides that Articles 2 and 3 took effect on July 1, 2026.
Article 2 amends selected provisions of Circular No. 32/2023/TT-BYT, including provisions concerning nursing technical activities and health examination documentation.
For nursing techniques marked with an asterisk in the relevant appendix, the amendment establishes transitional arrangements from July 1, 2026 through December 31, 2029. During this period, the person responsible for the healthcare facility's professional and technical operations may authorize eligible nurses to undertake the specified techniques through a written decision based on qualifications, competence and experience, and is responsible for that decision. Additional qualification and training requirements apply from January 1, 2030.
Article 3 amends Circular No. 23/2024/TT-BYT concerning lists of medical techniques and associated transition arrangements. Under the amended provisions, the relevant existing technical list remains applicable through December 31, 2027, with the subsequent list scheduled for implementation from January 1, 2028.
These provisions matter for healthcare facilities when reviewing professional assignments, technical authorization and service capabilities. They should not be interpreted as creating new clinical authority simply because an activity is described as Lifestyle Medicine.
An international Lifestyle Medicine certificate also does not independently expand a practitioner's authorized professional scope in Viet Nam.
For pathway design, the practical implication is that clinical activities must remain within the qualifications, competence, professional practice license and authorized scope of the practitioner, as well as the professional activities legally permitted at the healthcare facility.
The proposed clinical pathway discussed below is an organizational model for consideration and local adaptation. It is not a clinical pathway mandated by Circular No. 25/2026/TT-BYT or any other Vietnamese regulation.
A Proposed Lifestyle Medicine Clinical Pathway for Viet Nam
The following framework is presented by the Vietnam Lifestyle Medicine Alliance as a practical approach for professional discussion, organizational planning and pilot implementation.
It is not a validated national risk-stratification instrument, an official Ministry of Health treatment protocol or an independent accreditation requirement.
The pathway begins with a straightforward sequence:
Identify the patient → Assess clinical and lifestyle factors → Check for safety concerns → Stratify clinical risk → Select the appropriate care route → Agree on priorities → Deliver treatment and/or refer → Monitor and follow up → Review outcomes and improve care
The sequence may appear simple. Its safety depends on the decisions made within it.
Proposed Risk-Stratification and Care-Route Diagram
<escape>Patient identified for Lifestyle Medicine assessment</escape>
↓
Clinical assessment, medication review, lifestyle assessment and safety screening
↓
Apply relevant condition-specific risk criteria and professional judgment
↓
Select the appropriate clinical route
Route 1: Emergency or clinically unstable
Immediate emergency assessment and treatment through the organization's established emergency pathway. Lifestyle intervention must not delay urgent care.
Route 2: Time-sensitive clinical review
Prompt assessment by an appropriately qualified clinician when new symptoms, concerning findings, treatment-related risks or deterioration require attention. The response timeframe must follow the organization's approved clinical protocols.
Route 3: Structured or multidisciplinary clinical management
Coordinated care for clinically stable patients with established disease, greater treatment complexity or specialist needs. This route includes defined professional responsibilities, referrals, clinical monitoring and scheduled review.
Route 4: Routine prevention and focused lifestyle support
Evidence-based education or intervention for clinically stable individuals whose needs can be appropriately managed within routine care, with agreed goals, safety advice and follow-up.
↓
Document the decision, responsible clinician, referrals, monitoring requirements and next review
↓
Reassess and move between routes whenever the patient's clinical condition changes
These four routes are illustrative organizational categories. They are not validated Vietnamese clinical risk levels and should not replace relevant disease-specific assessment tools or clinical protocols.
The route should be determined by clinical urgency, risk, complexity and the capabilities of the service, not simply by how motivated a patient appears to be.
1. Identify Who Should Enter the Pathway
A healthcare organization should begin with a defined patient population rather than assume that every patient needs a comprehensive Lifestyle Medicine consultation.
A hospital might initially focus on people with hypertension, type 2 diabetes or established cardiovascular disease. A rehabilitation service may focus on functional recovery and appropriate physical activity. An outpatient clinic may begin with people who have identifiable cardiometabolic risk factors.
The choice should reflect a specific healthcare need and the organization's capacity to deliver appropriate care.
For example, a cardiometabolic service could identify patients whose disease management would benefit from more consistent dietary assessment, physical activity support, tobacco cessation interventions and treatment monitoring.
The reason for including a patient should be documented. The organization should also identify situations in which the proposed pathway is not appropriate or where other medical care must take priority.
Clear entry criteria help determine what information is needed, which professionals should be involved and what outcomes are worth measuring.
They also prevent unnecessary assessments and referrals.
Not everyone requires a lengthy questionnaire, an extensive laboratory investigation or a multidisciplinary consultation. The initial assessment should be proportionate to clinical need.
2. Make Assessment Clinically Relevant
Lifestyle assessment should provide information that can influence clinical decisions.
Depending on the patient's condition, this may include dietary patterns, physical activity, sedentary behavior, sleep, tobacco use, alcohol exposure, stress, emotional health, social connection and relevant social or environmental circumstances.
These factors should be considered alongside the clinical information needed to assess the underlying condition.
Current diagnoses, symptoms, treatment history, medication use, relevant clinical measurements, functional status and existing investigation results may all be important.
Medication reconciliation deserves particular attention when a substantial lifestyle intervention is being considered.
A patient taking insulin or certain other glucose-lowering medicines may require closer monitoring during major dietary or activity changes. Someone using blood-pressure medication may need review if an intervention is expected to produce substantial changes in blood pressure, hydration or body weight.
The purpose is not to discourage lifestyle intervention. It is to understand its clinical context before treatment begins.
There is no universal laboratory panel required for every Lifestyle Medicine patient. Investigations should have an identifiable clinical purpose and be consistent with relevant guidance.
Assessment tools also need careful selection. A questionnaire validated in one population may not automatically be suitable for another. Translation, cultural adaptation, intended use and interpretation should be considered when selecting tools for Vietnamese patients.
Most importantly, assessment should include what matters to the person.
A plan may be medically appropriate but impossible to sustain if it ignores work schedules, family commitments, financial circumstances, personal preferences or access to the recommended services.
3. Screen for Safety Before Starting or Intensifying Interventions
Lifestyle interventions are frequently described as low risk. Many are appropriate for broad populations, but clinical safety cannot be assumed in every situation.
Substantial dietary changes, intensive exercise, rapid weight loss and changes in alcohol consumption may have important consequences for people with particular diseases or treatments.
Persistent sleep problems may require evaluation for an underlying sleep disorder. Significant psychological symptoms may require more than general stress-management education. Physical activity may need modification when patients have unstable medical conditions or relevant functional limitations.
The safety screen should therefore identify whether the proposed intervention can proceed, requires modification or should be delayed pending further assessment.
A clinically unstable patient should not remain within a routine lifestyle-support pathway simply because the initial reason for attendance was prevention or behavior change.
The decision must be made according to relevant clinical guidance and the capabilities of the service.
Safety screening should also establish who will respond if the patient's condition changes after the consultation.
4. Define Referral and Escalation Triggers Before the Pathway Begins
A clinical pathway is incomplete if it advises staff to refer patients when necessary but does not explain how that decision will be made.
For each target population, the organization should identify the clinical findings, symptoms, investigation results and treatment-related concerns that trigger escalation.
These triggers should be linked to existing disease-specific guidelines, the organization's approved clinical protocols and appropriately validated assessment tools.
Emergency escalation is required when a patient develops a potentially life-threatening condition or other findings requiring immediate assessment and treatment. Examples include symptoms suggestive of an acute coronary syndrome or stroke, severe respiratory distress, loss of consciousness, severe hypoglycemia requiring assistance, or an immediate risk of self-harm. The appropriate emergency response should be activated without waiting for a scheduled Lifestyle Medicine review.
Time-sensitive medical review is appropriate when the patient is not clearly experiencing an immediate emergency but has findings that require prompt clinical attention. These may include symptomatic low blood pressure, recurrent hypoglycemia, concerning symptoms during physical activity, significant deterioration in mental health, suspected alcohol withdrawal or investigation results meeting the organization's criteria for urgent review.
Planned specialist referral may be appropriate for suspected obstructive sleep apnea, persistent insomnia requiring specialist assessment, eating disorders, complex nutritional needs, significant functional limitations, established complications of chronic disease or conditions that remain inadequately controlled despite appropriate care.
These examples are not exhaustive and do not constitute a new universal referral standard.
Numerical thresholds for blood pressure, blood glucose, laboratory results or other clinical findings should come from the relevant condition-specific guidance and locally approved protocols. They should not be invented as a separate Lifestyle Medicine risk score.
The organization should specify not only the trigger, but also the expected response, the professional authorized to make the clinical decision, the intended destination and the timeframe for action.
A referral threshold that nobody knows how to apply is unlikely to improve safety.
5. Stratify Risk Without Creating an Unvalidated Lifestyle Medicine Score
Clinical risk is multidimensional.
A person with stable hypertension may have very different needs from someone with the same diagnosis who also has advanced kidney disease, recurrent falls, unstable symptoms or complex medication requirements.
Cardiovascular risk, diabetes complications, falls risk, sleep-disorder risk, mental health risk and substance-use risk require different methods of assessment.
They should not automatically be combined into a single Lifestyle Medicine score.
Where suitable tools are available, organizations should use validated condition-specific approaches.
For example, the World Health Organization's HEARTS technical package supports a total cardiovascular risk approach in primary care and provides relevant resources for risk-based management.
The HEARTS package is not a Lifestyle Medicine clinical pathway, but its integrated approach illustrates how risk assessment, standardized treatment protocols, healthy-lifestyle counseling, team-based care and monitoring can support one another.
For a Vietnamese healthcare facility, practical risk stratification should consider clinical stability, established disease and complications, medication-related risks, functional limitations, mental health concerns and the resources needed to manage the patient safely.
The result should guide the intensity and location of care.
A patient who becomes clinically unstable must be reassessed, even if they were previously assigned to a routine-support route.
6. Match Care Intensity to Patient Needs
A clinically stable patient with limited complexity may benefit from a focused intervention, a small number of agreed goals and planned follow-up.
Someone living with an established chronic disease may need a more structured approach that includes medical review, clinical nutrition care, physical activity support or additional behavior-change assistance.
A person with multiple chronic conditions, substantial functional limitations or complex treatment requirements may require multidisciplinary assessment and closer monitoring.
These are different levels of clinical support, not different levels of personal motivation.
A patient who is uncertain about changing behavior may need additional communication and counseling. That uncertainty should never be used to withhold medically necessary assessment or treatment.
The intensity of care should be reviewed over time.
A patient may move from structured care to routine follow-up when their condition becomes stable. Conversely, new symptoms, complications or treatment-related problems may require reassessment and more intensive medical care.
A good pathway allows movement in both directions.
7. Agree on Priorities and Deliver Appropriate Interventions
The six major domains of Lifestyle Medicine provide a useful framework, but not every patient needs to work on all six at once.
Someone with hypertension, tobacco dependence, poor sleep and limited physical activity may receive a lengthy list of recommendations if every domain is addressed simultaneously.
Such a plan may appear comprehensive but be difficult to implement.
Clinical priorities should reflect the importance of each risk factor, the patient's medical condition and what the person can realistically change.
Shared decision-making is therefore central.
The healthcare professional contributes relevant evidence, clinical assessment and an understanding of treatment-related risks. The patient contributes goals, concerns, preferences and knowledge of their own circumstances.
The resulting plan should identify meaningful priorities and define what support is available.
Where treatment requires additional professional expertise, referral should be incorporated from the beginning rather than treated as a sign that the initial intervention has failed.
The selected intervention must also be delivered within the professional roles and authorized activities applicable to the healthcare facility.
8. Make Professional and Organizational Accountability Explicit
A multidisciplinary pathway can become unsafe when several professionals are involved but no one knows who is responsible for a particular decision.
The organization should therefore identify a clinical lead for the pathway and define the responsibilities of each participating service.
The clinician responsible for a patient's medical treatment should retain responsibility for the medical decisions within their authorized scope, including assessment of disease status and decisions concerning medication.
Nurses may contribute to appropriately authorized screening, education, care coordination, monitoring and follow-up. Clinical nutrition professionals may provide nutrition-related services within their roles. Rehabilitation professionals may contribute when functional assessment or therapeutic activity requires their expertise. Clinical psychologists and other mental health professionals may provide appropriate assessment and treatment within their authorized scopes.
Nonclinical educators and health coaches may support behavior change, but their involvement should not be interpreted as permission to diagnose disease or modify regulated medical treatment.
The organization should also define who coordinates referrals, who reviews incoming monitoring information, who follows up when appointments are missed and who ensures that safety concerns reach the appropriate clinician.
The person coordinating care is not necessarily the person authorized to make every clinical decision.
For a patient receiving care from several departments, the treating team should know which clinician is responsible for the overall clinical plan and which professional is accountable for each assigned intervention.
Responsibility should remain clear during handovers, staff absence and changes in the patient's condition.
9. Make Referral a Closed-Loop Process
Referral is an ordinary part of coordinated clinical care.
A patient may need clinical nutrition assessment, rehabilitation, specialist evaluation for sleep symptoms, mental healthcare or additional medical treatment.
The key question is not simply whether a referral was issued.
It is whether the patient received the intended assessment or treatment and whether the relevant information returned to the professionals responsible for ongoing care.
A closed-loop referral process should identify the reason for referral, the receiving service, the required urgency, the relevant clinical information and the person responsible for checking completion.
Where a referral is urgent, the organization should use an appropriate direct communication and handover process rather than assume that sending an electronic message is sufficient.
If the patient does not attend, the follow-up response should reflect clinical risk. A missed routine appointment and an incomplete urgent referral should not be handled in the same way.
The organization should also establish what happens when the receiving service cannot accept the patient or when an appropriate specialist is unavailable.
Referral does not necessarily mean that lifestyle-related support ends. In many cases, relevant interventions can continue alongside specialist care, provided treatment plans are compatible and responsibilities remain clear.
10. Make Follow-Up Part of Treatment
Lifestyle change usually takes time.
Patients may encounter difficulties after the initial consultation that were not apparent when the plan was developed. Work schedules change, symptoms emerge, medication requirements evolve or previously agreed goals become unrealistic.
Follow-up provides an opportunity to understand what happened and adjust the plan.
The interval should reflect clinical need rather than a fixed schedule applied to every patient.
Someone beginning a substantial intervention that may affect glucose levels or blood pressure may need closer monitoring than a clinically stable person receiving routine preventive counseling.
The responsible clinician should determine the appropriate monitoring and review arrangements, with support from other team members within their authorized roles.
Patients should understand which symptoms or findings require them to seek medical advice earlier than planned.
The organization should also clarify how patients can obtain help between appointments, particularly when monitoring identifies a potentially important clinical change.
Digital follow-up can be useful, but it should not create the impression that information is continuously monitored unless the service genuinely provides that capability.
A monitoring system is only useful when there is a reliable process for reviewing information and responding when necessary.
11. Medication Adjustment Must Remain Under Authorized Clinical Responsibility
Lifestyle intervention can produce clinically meaningful changes.
Blood pressure may decrease, glucose control may improve, body weight may change and symptoms may become less severe.
These outcomes can be beneficial, but they may also influence the safety or appropriateness of existing medication regimens.
For example, patients taking insulin or sulfonylureas may require particular attention to hypoglycemia risk during major dietary or physical activity changes. People taking antihypertensive medicines may develop symptoms requiring review if blood pressure falls substantially.
The pathway should therefore include a medication review process for patients whose interventions may affect treatment requirements.
Before a substantial intervention begins, the treating clinician should consider the patient's current medications, relevant risks and appropriate monitoring arrangements.
The plan should identify who will review clinical measurements, symptoms and other information that may indicate the need for treatment adjustment.
Medication initiation, dose adjustment, reduction or discontinuation must remain the responsibility of an appropriately authorized prescriber acting within the applicable clinical and legal framework.
Health coaches, educators and other professionals should not independently alter medical treatment merely because a patient reports improved lifestyle behaviors or better measurements.
Patients should also receive clear advice not to discontinue or change prescribed medicines on their own without appropriate professional guidance.
Where medication changes are clinically indicated, the decision should be documented and communicated to the relevant members of the care team.
The pathway must also recognize situations in which treatment needs to become more intensive.
If a patient's condition deteriorates or remains inadequately controlled, Lifestyle Medicine should not delay clinically indicated medication, diagnostic investigation, rehabilitation, specialist treatment or other appropriate care.
The objective is safer and more effective treatment, not medication reduction as an end in itself.
12. Monitor Adverse Events and Near Misses
A Lifestyle Medicine pathway should include an explicit approach to patient safety monitoring.
Organizations should not assume that an intervention is free from harm simply because it involves food, movement, sleep or other daily behaviors.
Potential safety concerns may include hypoglycemia during dietary changes, symptomatic hypotension, falls or injuries associated with physical activity, complications of inappropriate dietary restriction, unsafe alcohol withdrawal or deterioration in an underlying medical condition.
These events do not automatically establish that the Lifestyle Medicine intervention caused the problem. Clinical assessment is necessary to understand what occurred and whether the intervention, treatment plan, patient factors or other circumstances contributed.
The pathway should also recognize near misses, where a potentially unsafe situation is identified before harm occurs.
For example, a medication-related risk may be detected before a patient begins an intensive dietary intervention, or a proposed exercise plan may be modified after an important contraindication is recognized.
Recognizing such situations allows the team to improve safety before a more serious event occurs.
When an unexpected clinical problem occurs, the first responsibility is to ensure that the patient receives appropriate assessment and care.
The incident should then be documented, reviewed and reported through the applicable organizational processes.
In Vietnamese healthcare facilities, existing medical-incident management arrangements, including the applicable provisions of Circular No. 43/2018/TT-BYT on the prevention of medical incidents, provide an important framework for reporting, analysis, feedback and prevention.
Organizations should note that the circular excludes certain areas, including adverse drug reaction reporting and adverse events in clinical trials, which are subject to their own applicable processes.
Lifestyle Medicine programs should therefore connect with the facility's existing patient-safety, medication-safety and quality-management systems rather than establish a disconnected reporting structure.
The organization should identify who receives incident reports, who evaluates severity, who coordinates immediate action and who oversees analysis and improvement.
Serious incidents or recurring safety concerns may require broader organizational review, corrective actions and follow-up to determine whether those actions have been effective.
Safety monitoring should not be limited to counting events. It should examine how the pathway may have contributed to risk and what changes could reduce the likelihood of recurrence.
13. Document Decisions and Communicate Across the Team
A clinical pathway becomes difficult to manage when important information is scattered across paper worksheets, separate applications and conversations between professionals.
The clinical record should contain the information needed to support safe and coordinated care.
This includes relevant assessment findings, risk considerations, selected interventions, professional responsibilities, referral decisions, monitoring arrangements, medication changes, safety concerns and follow-up plans.
Documentation should be proportionate to clinical need. The objective is not to create unnecessary administrative work.
It is to ensure that important decisions remain visible and that responsibility can be understood when care moves between professionals or services.
Where several clinicians are involved, the team should be able to determine who made a particular decision, when it was made and which follow-up action was expected.
Digital monitoring systems may support this process, but they also introduce responsibilities involving data quality, security, access and confidentiality.
In Viet Nam, relevant requirements include Decree No. 102/2025/NĐ-CP on Health Data Management, effective July 1, 2025, and the Law on Personal Data Protection No. 91/2025/QH15, together with Decree No. 356/2025/NĐ-CP, both effective January 1, 2026.
Decree No. 330/2026/NĐ-CP, effective August 19, 2026, also establishes an administrative-sanctions framework in cybersecurity and personal-data protection.
Organizations using digital questionnaires, remote monitoring or external platforms should assess applicable legal obligations, determine appropriate data-access arrangements and establish clear responsibilities for handling patient information.
Collecting more data does not necessarily improve care. Information should be collected because it has a legitimate and defined clinical, operational or quality purpose.
14. Measure Clinical Performance and Patient Safety Together
A written pathway is not evidence that a program is functioning well.
Healthcare organizations need to examine whether the intended steps actually occur and whether the pathway improves care.
Process measures may include the proportion of eligible patients appropriately assessed, completion of relevant safety checks, documentation of agreed interventions, referral completion and follow-up attendance.
Behavioral outcomes may include changes in physical activity, tobacco use, dietary patterns or other relevant behaviors.
Clinical measures should be selected according to the target condition. Blood pressure, glycemic control, symptoms, physical functioning and other condition-specific indicators may be appropriate.
Patient-reported outcomes can provide additional information about quality of life, treatment burden, confidence in self-management and experience of care.
Safety measures should also be included from the beginning.
These may involve reported incidents and near misses, unexpected treatment-related problems, missed urgent follow-up, medication-related concerns and unplanned healthcare use where relevant.
An important distinction is that an increase in incident reports does not necessarily mean that care has become less safe. It may reflect improved detection and reporting. Interpretation should consider the clinical context, severity, exposure to risk and changes in reporting practices.
The organization should also consider the burden placed on patients and staff.
A pathway may produce some clinical improvements while requiring so much documentation or follow-up work that it becomes difficult to sustain.
Measurement should therefore include not only effectiveness, but also safety, feasibility, equity and organizational sustainability.
15. Apply the Pathway Within Existing Healthcare Services
The most appropriate model will depend on the healthcare setting.
In a hospital, Lifestyle Medicine may be integrated into an existing cardiometabolic, rehabilitation, perioperative or other relevant clinical pathway.
For example, a cardiometabolic service could combine assessment of lifestyle-related risks with established disease management, medication review, nutrition care, appropriate physical activity support and planned follow-up.
A perioperative service may address relevant nutritional, functional and behavioral factors before surgery, while ensuring that patients receive appropriate medical assessment and do not delay necessary treatment.
Cancer services may incorporate evidence-based nutrition, physical activity and psychosocial support as part of comprehensive care without presenting Lifestyle Medicine as a replacement for cancer-specific treatment.
In outpatient clinics, a simpler approach may be preferable. A brief, relevant assessment can help identify patients suitable for focused support and those requiring additional professional input.
A smaller clinic may not have access to every discipline internally. In that situation, reliable referral relationships and clear responsibility for follow-up may be more valuable than attempting to establish a comprehensive Lifestyle Medicine service immediately.
Primary care offers particular opportunities because it supports earlier risk identification and longitudinal management.
In September 2026, the World Health Organization reported that its collaborative initiative with the Government of Viet Nam and Resolve to Save Lives was supporting the screening of approximately 10 million people annually and treatment for more than two million people through strengthened grassroots healthcare services addressing hypertension and diabetes.
The initiative demonstrates the value of coordinated primary care, standardized treatment, referral mechanisms and monitoring.
Lifestyle Medicine can complement such efforts by strengthening appropriate behavioral assessment, individualized support and continuity of care.
The WHO HEARTS technical package offers a useful international reference for integrating healthy-lifestyle counseling with clinical risk management, treatment protocols, team-based care and monitoring systems.
It should not, however, be described as an officially adopted Vietnamese Lifestyle Medicine pathway.
16. Start With a Manageable Pilot
Organizations do not need to implement every component of Lifestyle Medicine across all departments at once.
A more practical approach is to select one patient population, identify a meaningful care problem and test a pathway that the organization can realistically support.
The initial design should define the target population, relevant assessment requirements, clinical risk criteria, authorized professional roles, referral arrangements, monitoring responsibilities and intended outcomes.
Before implementation, the organization should also test how the pathway responds to safety concerns.
What happens if a patient develops symptoms requiring urgent assessment? Who reviews abnormal monitoring results? Who contacts the patient when a clinically important referral is not completed? Who is authorized to reassess and adjust medication? Who receives reports of unexpected events?
These questions are best answered before the first patient enters the program.
A pilot should then examine whether the pathway functions as intended.
Some problems may be operational rather than clinical. Staff may duplicate documentation, referrals may take too long, patients may be given unrealistic plans or follow-up information may not reach the responsible clinician.
Quality-improvement methods can help teams identify these problems, test changes and assess their effects.
The objective is not to demonstrate that a new program is successful at all costs. It is to learn whether the approach is useful, safe and sustainable.
A pathway that reveals its own weaknesses and improves through measurement may be more valuable than one that reports only positive results.
17. What Should Healthcare Organizations Avoid?
The development of Lifestyle Medicine in Viet Nam should avoid creating unnecessary parallel systems.
A new clinic, questionnaire or digital platform does not automatically improve care.
Organizations should avoid universal assessment packages that are unrelated to clinical need, unvalidated risk scores and rigid follow-up schedules that do not reflect patient circumstances.
They should not assume that all patients can safely undertake intensive lifestyle interventions or that every patient will benefit from the same approach.
International certificates should not be presented as substitutes for Vietnamese professional authorization.
Lifestyle interventions should not delay necessary medical care, and medication reduction should not become a measure of program success without appropriate clinical justification.
Referral should not be considered failure. For patients with complex needs, timely specialist assessment may be one of the most important benefits of a well-designed pathway.
Organizations should also avoid relying entirely on one enthusiastic professional.
A reliable pathway should continue functioning when staff members change, patients move between services or the responsible clinician is temporarily unavailable.
The measure of a good pathway is not its complexity. It is whether the right decisions are made, responsibilities remain clear and patients receive appropriate care at the right time.
From Lifestyle Advice to Reliable Clinical Care
Lifestyle Medicine has the potential to strengthen prevention and chronic disease management in Viet Nam, but that potential will not be realized through education and general recommendations alone.
Clinical integration requires more than explaining the benefits of nutrition, physical activity, sleep or other health behaviors.
It requires a defined patient population, clinically relevant assessment, appropriate risk stratification, clear referral and escalation criteria, authorized professional roles, medication safety, follow-up and systematic monitoring.
It also requires organizations to recognize when a lifestyle intervention should be modified, when additional treatment is necessary and when a patient must move into another clinical pathway.
Viet Nam's evolving disease-prevention framework provides a supportive environment for strengthening these approaches, but implementation must remain consistent with the country's healthcare licensing requirements and professional regulations.
International competencies and scientific evidence can inform pathway design. Existing Vietnamese clinical guidance, healthcare governance and local experience must determine how it is implemented.
A useful Lifestyle Medicine pathway should ultimately be able to answer four questions about every patient:
What does this person need next? Who is responsible? How will we know that the care is safe? And how will we know whether it helped?
Those questions are more important than the name placed on the service.
If healthcare organizations can answer them consistently, Lifestyle Medicine can become a more reliable and meaningful part of clinical care in Viet Nam.
References and Further Reading
Rea BL, Cheema S, Lanza S, et al. Lifestyle Medicine Core Competencies: 2025 Update. American Journal of Lifestyle Medicine. 2026;20(3):443–451. doi:10.1177/15598276251379821.
World Health Organization Viet Nam. Strengthened Grassroots Health Care Brings Noncommunicable Disease Services to 10 Million in Viet Nam. September 8, 2026.
National Assembly of Viet Nam. Law on Disease Prevention No. 114/2025/QH15. Adopted December 10, 2025; effective July 1, 2026.
Government of Viet Nam. Decree No. 165/2026/NĐ-CP Detailing and Guiding Implementation of Selected Provisions of the Law on Disease Prevention. Issued May 15, 2026; effective July 1, 2026.
Ministry of Health of Viet Nam. Circular No. 15/2026/TT-BYT Detailing Selected Provisions of the Law on Disease Prevention. Issued May 17, 2026; effective July 1, 2026.
Office of the National Assembly of Viet Nam. Consolidated Document No. 26/VBHN-VPQH: Law on Medical Examination and Treatment. February 26, 2026.
Government of Viet Nam. Decree No. 96/2023/NĐ-CP Detailing Selected Provisions of the Law on Medical Examination and Treatment. Issued December 30, 2023; effective January 1, 2024.
Ministry of Health of Viet Nam. Circular No. 32/2023/TT-BYT Detailing Selected Provisions of the Law on Medical Examination and Treatment, as amended.
Ministry of Health of Viet Nam. Circular No. 25/2025/TT-BYT Detailing Implementation of Selected Provisions of the Law on Social Insurance, the Law on Occupational Safety and Health, and the Law on Medical Examination and Treatment. Issued June 30, 2025.
Ministry of Health of Viet Nam. Circular No. 25/2026/TT-BYT, dated June 30, 2026, amending selected provisions of Circulars No. 01/2013/TT-BYT, No. 32/2023/TT-BYT, No. 23/2024/TT-BYT and No. 42/2025/TT-BYT. General effective date: August 15, 2026. Articles 2 and 3 effective July 1, 2026, pursuant to Article 6, Clause 2.
World Health Organization. HEARTS: Technical Package for Cardiovascular Disease Management in Primary Health Care: Risk-Based Cardiovascular Disease Management. Geneva: World Health Organization; 2020.
World Health Organization. HEARTS: Technical Package for Cardiovascular Disease Management in Primary Health Care: Healthy-Lifestyle Counselling. Geneva: World Health Organization; 2018.
World Health Organization. HEARTS: Technical Package for Cardiovascular Disease Management in Primary Health Care: Team-Based Care. Geneva: World Health Organization; 2018.
World Health Organization. HEARTS: Technical Package for Cardiovascular Disease Management in Primary Health Care: Systems for Monitoring. Geneva: World Health Organization; 2018.
Ministry of Health of Viet Nam. Circular No. 43/2018/TT-BYT on the Prevention of Medical Incidents in Medical Examination and Treatment Facilities. Issued December 26, 2018; effective March 1, 2019, subject to applicable subsequent amendments.
Government of Viet Nam. Decree No. 102/2025/NĐ-CP on Health Data Management. Issued May 13, 2025; effective July 1, 2025.
National Assembly of Viet Nam. Law on Personal Data Protection No. 91/2025/QH15. Adopted June 26, 2025; effective January 1, 2026.
Government of Viet Nam. Decree No. 356/2025/NĐ-CP Detailing Selected Provisions and Implementation Measures of the Law on Personal Data Protection. Issued December 31, 2025; effective January 1, 2026.
Government of Viet Nam. Decree No. 330/2026/NĐ-CP on Administrative Penalties for Violations in Cybersecurity and Personal Data Protection. Issued and effective August 19, 2026.
Implementation and Clinical Governance Note
This article is intended for professional education, organizational planning, quality improvement and discussion of potential Lifestyle Medicine clinical pathways in Viet Nam. The proposed framework is not an official Vietnamese national clinical guideline, a validated risk-stratification instrument, a medical licensing framework, an accreditation standard or a substitute for condition-specific clinical guidance.
The risk-stratification routes, referral considerations and organizational responsibilities described here are illustrative and require local clinical review, formal adoption where appropriate and adaptation to the patient population, available resources and applicable professional and legal requirements.
Healthcare organizations should use relevant evidence-based clinical guidance, approved assessment and escalation protocols, appropriately authorized professional roles, established medication-safety and medical-incident management processes, and applicable health-data and personal-data protection requirements.
International Lifestyle Medicine training, certification or professional membership does not independently authorize regulated clinical activities or extend professional scope under Vietnamese law. Decisions concerning diagnosis, treatment, medication adjustment, emergency care and referral must remain under the responsibility of appropriately qualified and authorized healthcare professionals.
Vietnam Lifestyle Medicine Alliance
Evidence-Based Lifestyle Medicine for Viet Nam.
Contact
contact@vlma.org
Saigon Paragon Building, No. 3 Nguyen Luong Bang Street, Tan My Ward, HCMC
+84 909 228 476
+84 84 9999 911
© 2025 - 2026. Vietnam Lifestyle Medicine Alliance. All rights reserved.
A physician-led professional platform advancing Lifestyle Medicine through education, collaboration, research, and responsible implementation.
VLMA is operated by Vietnam Lifestyle Medicine Alliance Company Limited, Enterprise Registration Number 0318902666.
VLMA is a Sister Organization of the Lifestyle Medicine Global Alliance and a Member Organization of the Planetary Health Alliance.
VLMA is not a medical service provider and does not issue medical licenses or IBLM certification.
